Rays Power Infra announced closure of INR 127 Crore Equity Capital Fund Raise - Second Act Awards 2026 Celebrate Courage, Reinvention and Meaningful New Beginnings Meenakashi Lekhi attended the Mumbai event as Chief Guest as entrepreneurs, artists and changemakers were honoured for rewriting their life stories - Prestigious Asia’s Modern Hero Award 2026 Dr. Nilesh Potdar Honoured with Asia’s Modern Hero Award 2026 - Maharashtra’s Culture Comes Alive in Berlin as ‘Ganpati Bappa Morya’ Echoes Across the City - Matrimonial Dispute Widens Into Parallel Legal Proceedings Across Delhi and Uttar Pradesh A June 2025 complaint by Ayush Gupta preceded Nikita Jaiswal’s September 2025 Kanpur FIR; subsequent proceedings have brought documentary evidence, competing allegations and judicial scrutiny into the public record - Five-Year-Old Boy with Relapsed Leukemia is Cancer-Free after Haploidentical Bone Marrow Transplant at Kokilaben Hospital, Navi Mumbai - Orient Cables (India) Limited Announced its ₹5,520.00 million Initial Public Offering (IPO) to open on September 25, 2026 Price Band fixed at ₹258 to ₹272 per equity share of face value of ₹1 each - AceVector Limited Announced it's Initial Public Offer (IPO) of Equity Shares to open on September 25, 2026, Price Band is fixed at ₹ 30 to ₹ 32 per equity share of face value of ₹ 1 each - Moneyview Limited announced its Initial public offering (IPO) to open on Thursday, September 24, 2026 Price Band fixed at ₹32 per equity share of face value ₹1 each to ₹34 per equity share of the face value of ₹1 each - Moneyview Limited announced it's Initial public offering (IPO) to open on Thursday, September 24, 2026 Price Band fixed at ₹32 per equity share of face value ₹1 each to ₹34 per equity share of the face value of ₹1 each - BVG India awarded contract of Chambal Riverfront to Develop a Destination for Sustainable Urban Living and Tourism

Victory! Central Government Committee Withdraws Plan to Use Stray Dogs for Drug Testing 

New Delhi, 12th October 2023 (GNI): In a watershed moment for animal welfare and scientific advancement, the Committee for Control and Supervision of Experiments on Animals (CCSEA) – a statutory body constituted under The Prevention of Cruelty to Animals Act, 1960 – has withdrawn until further orders its recommendation to use stray dogs in vaccine trials.  

Last year, PETA India raised serious concerns that the Committee’s recommendation would open the floodgates not only for stray dogs but also for other feral animals to be used in experiments, such as painful efficacy and toxicity testing, dissections, and demonstrations. In a letter, PETA India urged the CCSEA to withdraw its recommendation in favour of animal-free research methods. 

PETA India points out that using dogs in vaccine development, whether they are obtained from a breeding facility or taken from the streets, leads science down the wrong road. Extensive peer-reviewed literature has established that the results of tests on animals, including dogs, can’t reliably predict how humans will respond to new medicines, which ultimately delays the approval of effective treatments and cures for human health conditions. 

“Reliance on tests using stray dogs and other animals to predict human responses to vaccines, drugs, and treatments is scientifically unsound and deeply troubling on ethical grounds,” says PETA India Science Policy Advisor Dr Ankita Pandey. “We applaud the CCSEA for withdrawing a regressive policy that would have negatively affected science, animal welfare, and public health.” 

In its letter, PETA India pointed out that the recommendation to use stray dogs contravened the duties assigned to the CCSEA by the Government of India under Rule 10 of the Breeding of and Experiments on the Animals (Control and Supervision) Amendment Rules, 2006, which states that, except in rare circumstances, “an establishment shall acquire animal(s) for experiments from registered breeders only”. The CCSEA’s recommendation, the letter noted, contradicted policies adopted by the EU, the UK, the US, and Australia, which are India’s competitors in science and technology. 

This news release is available in Hindi here. 

PETA India – whose motto reads, in part, that “animals are not ours to experiment on” – opposes speciesism, a human-supremacist worldview. For more information, please visit PETAIndia.com or follow the group on X (formerly Twitter), Facebook, or Instagram. Ends

Be the first to comment on "Victory! Central Government Committee Withdraws Plan to Use Stray Dogs for Drug Testing "

Leave a comment

Your email address will not be published.


*